| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |